TUDEYRO Trademark

Trademark Overview


On Thursday, December 13, 2018, a trademark application was filed for TUDEYRO with the United States Patent and Trademark Office. The USPTO has given the TUDEYRO trademark a serial number of 79251156. The federal status of this trademark filing is CANCELLED - SECTION 7 as of Monday, February 26, 2024. This trademark is owned by NOVARTIS AG. The TUDEYRO trademark is filed in the Pharmaceutical Products category with the following description:

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the pr...
tudeyro

General Information


Serial Number79251156
Word MarkTUDEYRO
Filing DateThursday, December 13, 2018
Status711 - CANCELLED - SECTION 7
Status DateMonday, February 26, 2024
Registration Number5796614
Registration DateTuesday, July 9, 2019
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 23, 2019

Trademark Statements


Goods and ServicesAnti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and the treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code1 - Sec. 7(d) - Entire Registration
Class Status DateMonday, February 26, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNOVARTIS AG
Party Type30 - Original Registrant
Legal Entity Type25 - NOT AVAILABLE
AddressBasel CH-4002
CH

Party NameNOVARTIS AG
Party Type20 - Owner at Publication
Legal Entity Type25 - NOT AVAILABLE
AddressCH

Party NameNOVARTIS AG
Party Type10 - Original Applicant
Legal Entity Type25 - NOT AVAILABLE
AddressCH

Trademark Events


Event DateEvent Description
Thursday, February 7, 2019SN ASSIGNED FOR SECT 66A APPL FROM IB
Saturday, February 9, 2019LIMITATION FROM ORIGINAL APPLICATION ENTERED
Monday, February 11, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, February 15, 2019APPLICATION FILING RECEIPT MAILED
Sunday, March 10, 2019ASSIGNED TO EXAMINER
Monday, March 11, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 3, 2019NOTICE OF PUBLICATION
Tuesday, April 23, 2019PUBLISHED FOR OPPOSITION
Tuesday, July 9, 2019REGISTERED-PRINCIPAL REGISTER
Thursday, August 8, 2019GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Saturday, August 31, 2019FINAL DISPOSITION PROCESSED
Saturday, August 31, 2019FINAL DISPOSITION NOTICE SENT TO IB
Thursday, September 19, 2019NOTIFICATION PROCESSED BY IB
Wednesday, June 21, 2023REQUEST FOR SECT 7 TOTAL SURRENDER FILED
Wednesday, June 21, 2023TEAS SECTION 7 SURRENDER RECEIVED
Monday, February 26, 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, February 26, 2024CANCELLED SECTION 7-TOTAL
Tuesday, February 27, 2024NOTICE OF CANCELLATION SEC. 7 SURRENDER EMAILED
Monday, October 28, 2024TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, November 15, 2024TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Friday, November 15, 2024INVALIDATION PROCESSED
Saturday, December 7, 2024TOTAL INVALIDATION PROCESSED BY THE IB